Literature DB >> 2729749

The appearance of hypodense eosinophils in antigen-dependent late phase asthma.

W E Frick1, J B Sedgwick, W W Busse.   

Abstract

Although peripheral blood eosinophils (EOS) of low density are increased in patients with asthma, the mechanisms contributing to their presence are not well established. The following study evaluated the effect of an antigen bronchoprovocation (BP) on the percentage of circulating hypodense eosinophils (HE) in asthma. EOS density was measured by centrifugation of peripheral blood granulocytes over multiple discontinuous density Percoll gradients in samples taken immediately before and 24 h after antigen BP. We found that the percentage of peripheral blood HE (density less than 1.095 g/ml) increased significantly (p less than 0.02) over baseline values (78.9 +/- 4.8% versus 53.3 +/- 8.2%, mean +/- SEM, n = 11) when evaluated 24 h after antigen BP but only in patients who experienced both an immediate (IAR) and late phase asthma reaction (LAR). No significant change in the percentage of HE was observed in asthma subjects who had only an early asthma response to inhaled antigen (n = 6). In an expanded population of allergic asthmatics (n = 38), a significant correlation was found between the percent peripheral blood HE and disease severity as represented by the percent predicted FEV1 (r = -0.56, p = 0.003). These data suggest that in vivo activation of asthma by inhaled antigen increases the proportion of peripheral blood EOS that are hypodense but only in those patients with both an IAR and LAR. Furthermore, we also conclude that the percentage of HE better reflects the severity of asthma than the concentration of total peripheral blood eosinophils.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729749     DOI: 10.1164/ajrccm/139.6.1401

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Transcriptional regulation of the IL-5 gene in peripheral T cells of asthmatic patients.

Authors:  K Ogawa; O Kaminuma; H Okudaira; H Kikkawa; K Ikezawa; N Sakurai; A Mori
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

Review 3.  Update on clinical and immunological features of eosinophilic gastrointestinal diseases.

Authors:  Joanne C Masterson; Glenn T Furuta; James J Lee
Journal:  Curr Opin Gastroenterol       Date:  2011-10       Impact factor: 3.287

Review 4.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

5.  Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.

Authors:  E Coëffier; D Joseph; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Clinical value of monitoring eosinophil activity in asthma.

Authors:  D Y Koller; Y Herouy; M Götz; E Hagel; R Urbanek; I Eichler
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

Review 7.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats.

Authors:  A Watanabe; H Mishima; P M Renzi; L J Xu; Q Hamid; J G Martin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Allergen-induced airway responses in rats pretreated with Sephadex.

Authors:  P Rossi; L Xu; N S Wang; J G Martin
Journal:  Agents Actions       Date:  1993-11

10.  Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation.

Authors:  L Yang; L Cohn; D H Zhang; R Homer; A Ray; P Ray
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.